Improvement in Patient-Reported Outcomes in a Rituximab Trial in Patients With Severe Rheumatoid Arthritis Refractory to Anti-Tumor Necrosis Factor Therapy. - Keystone, E.; Burmester, G. R.; Fume, R.; Loveless, J. E.; Emery, P.; Kremer, J.; Tak, P. P.; Broder, M. S.; Yu, E.; Cravets, M.; Magrini, F.; Jost, F. (Arthritis & Rheumatism, 2008)